The storied success of sildenafil has undeniably transformed the drug landscape. However, wagering in companies heavily focused on biosimilars and the waning patent protection surrounding this flagship https://olivebookmarks.com/story21476943/sildenafil-and-drugmakers-a-risky-opportunity